How to Refill a Testosterone Prescription (TRT)

Why do TRT refills work differently from other prescriptions?

Testosterone and other anabolic steroids are federally classified as Schedule III controlled substances under the Controlled Substances Act 1Ref 1Drug Enforcement Administration (2024).21 C.F.R. Part 1306 — Prescriptions: Schedules III, IV, and V controlled substances (including § 1306.22 Refilling of Prescriptions).Testosterone as a Schedule III controlled substance; limit of five refills within six months; requirement for prescriber authorization at each refill — no automatic refills. This means pharmacies cannot automatically refill them, early refills are often restricted, and prescribers must follow specific rules that vary by state and by whether therapy is managed in person or via telehealth. Under 21 C.F.R. § 1306.22, a Schedule III prescription may be refilled up to five times within six months of the issue date — but each refill still requires prescriber authorization, not passive automatic dispensing 1Ref 1Drug Enforcement Administration (2024).21 C.F.R. Part 1306 — Prescriptions: Schedules III, IV, and V controlled substances (including § 1306.22 Refilling of Prescriptions).Testosterone as a Schedule III controlled substance; limit of five refills within six months; requirement for prescriber authorization at each refill — no automatic refills. The process is not arbitrary; it is a legal requirement.

What is the standard refill path?

Most prescribers who manage TRT use one of these approaches:

Routine monitoring visit, then prescription: Your prescriber sees you periodically — commonly every 3 to 6 months — to check labs (at minimum testosterone levels, and often hematocrit, PSA, and sometimes liver function) 2Ref 2Mulhall JP, Trost LW, Brannigan RE, et al. (2018).Evaluation and Management of Testosterone Deficiency: AUA Guideline.Follow-up monitoring requirements during TRT: hematocrit threshold (>54% requires action), PSA monitoring, testosterone level checks every 6–12 months. After a satisfactory visit, they authorize your next supply.

Telehealth platform with built-in refill workflow: Many men's health telehealth services — including Gale — handle refills via secure messaging, asynchronous check-ins, or brief follow-up visits, then send a new prescription to a pharmacy or mail-order service. If you started TRT through a telehealth service, their patient portal is usually the right starting point.

Primary care or endocrinology: Contact them to request a refill and ask whether labs are due before they will authorize it.

What should you do if you are running low?

Contact your prescribing practice before you run out — ideally with at least 1 to 2 weeks of supply remaining. Controlled-substance prescriptions take longer to process, and pharmacies cannot bridge you the way they sometimes can with non-controlled medications.

When you contact your practice, ask: - Are labs required before the next prescription? - Can this be handled through the portal, or do I need a visit? - What is the expected turnaround time?

If you run out and cannot reach your prescriber quickly, an urgent care or telehealth visit for a bridge prescription is possible but not guaranteed — practices vary on prescribing controlled substances to new patients. Planning ahead is far easier.

Why ongoing monitoring is built into the refill process

Monitoring while on TRT protects you. The AUA Testosterone Deficiency Guideline recommends checking testosterone levels (to confirm you are in the therapeutic range), hematocrit (testosterone raises red blood cell production, and elevated hematocrit above 54% increases clotting risk), and PSA, typically every 6 to 12 months once stable 2Ref 2Mulhall JP, Trost LW, Brannigan RE, et al. (2018).Evaluation and Management of Testosterone Deficiency: AUA Guideline.Follow-up monitoring requirements during TRT: hematocrit threshold (>54% requires action), PSA monitoring, testosterone level checks every 6–12 months. How often depends on how stable your levels are.

A lower-cost refill program that skips adequate monitoring is not a bargain. The monitoring is the safety mechanism.

A note on unsupervised sources

Online or gray-market testosterone without a prescription is not a safe workaround. Unregulated products carry real risks — counterfeit or contaminated medication, unmonitored hematocrit rise, and no dose guidance. A 2024 meta-analysis of 30 randomized controlled trials found that TRT is associated with meaningful hematocrit elevation, underscoring why clinical oversight matters 3Ref 3Jaiswal V, Sawhney A, Nebuwa C, et al. (2024).Association between Testosterone Replacement Therapy and Cardiovascular Outcomes: A Meta-analysis of 30 Randomized Controlled Trials.Safety rationale for ongoing monitoring during TRT; elevated hematocrit as a real risk requiring clinical oversight rather than unsupervised use. The safer path is a regular prescribing relationship with a clinician who knows your labs 2Ref 2Mulhall JP, Trost LW, Brannigan RE, et al. (2018).Evaluation and Management of Testosterone Deficiency: AUA Guideline.Follow-up monitoring requirements during TRT: hematocrit threshold (>54% requires action), PSA monitoring, testosterone level checks every 6–12 months.